(NASDAQ: CNXU) Conexeu Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.51%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.42%.
Conexeu Sciences's earnings in 2026 is N/A.On average, 3 Wall Street analysts forecast CNXU's earnings for 2026 to be -$11,508,333, with the lowest CNXU earnings forecast at -$11,057,026, and the highest CNXU earnings forecast at -$11,846,813. On average, 3 Wall Street analysts forecast CNXU's earnings for 2026 to be -$11,508,333, with the lowest CNXU earnings forecast at -$11,057,026, and the highest CNXU earnings forecast at -$11,846,813.
In 2027, CNXU is forecast to generate -$15,248,541 in earnings, with the lowest earnings forecast at -$14,650,559 and the highest earnings forecast at -$15,697,027.